Clinical trial Recruiting at 1 site Observational

Assessing late effects in childhood cancer survivors in Aarau, Switzerland

Official title: Young Survivors at Kantonsspital Aarau, Switzerland - A Standardized Assessment of Long-Term and Late-Onset Health Events in Survivors of Childhood and Adolescent Cancer

Run by Kantonsspital Aarau · NCT04811794 · Data updated 2026-11-12

This study looks at the long-term health effects that childhood cancer survivors experience after their treatment to help improve their follow-up care.

More Childhood Cancer trials

Quick facts

Study typeObservational
SexAll
Enrollment300 (estimated)
SponsorKantonsspital Aarau
Academic / other
Locations1 site (Aarau)
StatusRecruiting
StartedMarch 15, 2021
Main results expectedMarch 15, 2071
Study endsMarch 15, 2072
Registry record updatedAugust 17, 2022
Trial IDNCT04811794 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include children and adolescents who have been treated for cancer at Kantonsspital Aarau and are currently in follow-up care.

Probably not a fit

Patients in a palliative situation or those who have not consented to the use of their medical data may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Young Survivors at Kantonsspital Aarau project focuses on evaluating the prevalence and severity of late effects experienced by survivors of childhood and adolescent cancer. This observational study collects clinical data during regular follow-up visits, starting immediately after treatment completion and continuing longitudinally. By utilizing standardized criteria for severity coding, the study aims to overcome limitations of previous retrospective studies and enhance understanding of long-term outcomes for these survivors. The findings will inform improvements in follow-up care for childhood cancer survivors.

Why it matters

Potential benefit: If successful, this study could lead to better long-term care and management strategies for childhood cancer survivors experiencing late effects.

How similar studies have gone: While many studies on late effects have been retrospective, this prospective approach aims to fill gaps in existing research, making it a novel contribution to the field.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Group A:

Children and adolescents who:

* have been treated for cancer in the Division of Oncology-Hematology, Department of Pediatrics, at the Kantonsspital Aarau,
* have been diagnosed at age 0-18 years,
* are still in regular follow-up care at the Kantonsspital Aarau,
* have finished cancer treatment and entered follow-up care, and
* signed informed consent

Group B:

Adolescents and adults who:

* fulfill the same inclusion criteria as Group A
* are not in regular follow-up care anymore

Exclusion Criteria:

Childhood Cancer Survivors who:

* are in a palliative situation or
* have not given consent for further use of medical data

Where it's running

  • Division of Oncology - Hematology, Department of Pediatrics, Kantonsspital Aarau
    Aarau, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.